Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia

NCT00637234 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT00637234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00637234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia
Lead sponsor
University of Cologne
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2004
Completion date
July 31, 2008
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia